Advertisement
Advertisement
BIO.B
Bio-Rad Laboratories, Inc. Class B
290.00
USDSponsored
-14.15
-4.65%
Jun 23, 15:59 UTC -4
Closed
After-Market
289.28
-0.72
-0.25%
BIO.B Earnings Reports
Positive Surprise Ratio
BIO.B beat 29 of 42 last estimates.
69%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q2 26 (Revenue/ EPS)
$630.23M
/$1.76
Implied change from Q1 26 (Revenue/ EPS)
+6.44%
/-6.88%
Implied change from Q2 25 (Revenue/ EPS)
-3.28%
/-32.57%
Bio-Rad Laboratories, Inc. Class B earnings per share and revenue
On Apr 30, 2026, BIO.B reported earnings of 1.89 USD per share (EPS) for Q1 26, missing the estimate of 2.00 USD, resulting in a -5.68% surprise. Revenue reached 592.10 million, compared to an expected 594.76 million, with a -0.45% difference.
Looking ahead to Q2 26, 6 analysts forecast an EPS of 1.76 USD, with revenue projected to reach 630.23 million USD, implying an decrease of -6.88% EPS, and increase of 6.44% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Bio-Rad Laboratories, Inc. Class B's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Bio-Rad Laboratories, Inc. Class B reported EPS of $1.89, missing estimates by -5.68%, and revenue of $592.10M, -0.45% below expectations.
How did the market react to Bio-Rad Laboratories, Inc. Class B's Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Bio-Rad Laboratories, Inc. Class B expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Bio-Rad Laboratories, Inc. Class B's next earnings report?
Based on 6
analysts, Bio-Rad Laboratories, Inc. Class B is expected to report EPS of $1.76 and revenue of $630.23M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement